Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens

Primerdesign launches new animal multiplex assays at London Vet Show

Rapid, accurate detection of six gastrointestinal disease-causing pathogens in cats and dogs.

Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the

Yourgene Health and Genetix launch first local non-invasive prenatal testing service in Colombia

Manchester, UK, and B

ELRIG UK and The Protein Society partner to advance protein sciences in drug discovery

Cambridge, UK and Los Angeles, US: The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, has partnered with The

Primerdesign launches real-time PCR workflow for onsite detection of Norovirus in Oysters

ELRIG UK announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024

Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October

ELRIG UK and SRG announce partnership to advance life science professionals in drug discovery

Partnership endorses mission to facilitate career progression and support life science industry growth.

CryoLogyx completes £500k seed funding round

ELRIG UK announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation 2024

Yourgene Health becomes a PacBio Compatible Partner: enabling PacBio customers to optimise size selection for long-read sequencing libraries

Yourgene’s LightBench® instrument offers precise and accurate size selection of PacBio® SMRTbell® sequencing libraries increasing HiFi sequencing yields

Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria

Yourgene Health and Laboriad launch non-invasive prenatal testing in Morocco

Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents

ELRIG UK establishes Engagement Strategy Work Group

Cambridge, UK, 14 September 2023: The European Laboratory Research & Innovation Group (ELRIG) UK announces the formation of its Engagement Strategy Work Group (ESWG).

Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow.

TherageniX and University of Nottingham Awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

London, UK, and Nottingham, UK - TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene…

Yourgene Health presents data demonstrating successful Fetal Fraction Enrichment in NIPT Workflows following prolonged blood storage in EDTA Tubes

•    Extended EDTA blood tube storage offers improved flexibility and cost-saving in NIPT workflows  •    Collaborative study with Tommy’s Charity and St Mary’s NHS Hospital, Manchester •    Data presented at ISPD 2023 in Edinburgh, UK

ELRIG UK Announces Prof Janet Hemingway and Dr Dave Powell as Keynote Speakers at Drug Discovery 2023

ELRIG Drug Discovery 2023 at ACC Liverpool (18–19 October) to focus on diverse thinking and new perspectives

ELRIG UK appoints Nick Clare to Board as Vendor Strategy Work Group Lead

Cambridge, UK - The European Laboratory Research & Innovation Group (ELRIG) UK announces the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.